NDC discrepancies: why your wholesaler substitution is not fraud

If you've ever opened a PBM audit letter and seen the phrase "NDC discrepancy," you already know the feeling. Your records look clean. The prescription was filled correctly. The patient got the right medication. And yet the PBM is treating a single-digit code mismatch as an overpayment — and demanding the money back.

NDC discrepancy findings are one of the most common audit triggers independent pharmacies face in 2026, and they are also one of the most misunderstood. The underlying issue is almost always documentation, not dispensing. But PBMs have every incentive to characterize these findings as serious compliance failures, because each one unlocks a recoupment.

This guide walks through what an NDC discrepancy actually is, why wholesaler substitutions trigger them so often, and what documentation each major PBM requires to overturn the finding.

What an NDC discrepancy actually means

The National Drug Code, or NDC, is an 11-digit product identifier assigned by the FDA to every prescription medication. The first five digits identify the manufacturer or labeler. The middle four identify the product. The last two identify the package size. Every time your pharmacy fills a prescription, you submit an NDC on the claim you transmit to the PBM.

An NDC discrepancy arises when the NDC you submitted on the claim does not exactly match the NDC printed on the purchase invoice you received from your wholesaler. In PBM audit language, this is treated as evidence that the medication billed does not match the medication purchased. In practice, it almost always means something far less dramatic.

The three most common causes of a "discrepancy"

In our experience translating audit notices for independent pharmacies, NDC mismatches fall into three categories — and none of them involve wrongdoing.

First, wholesaler substitution. When you order a medication from your primary wholesaler, you submit a purchase order with a specific NDC. But if that NDC is out of stock, the wholesaler will often substitute a therapeutically identical product from a different labeler — same drug, same strength, same package size, different NDC. The substitution is legal, clinically appropriate, and standard industry practice. But if your claim shows the original NDC and your invoice shows the substituted one, a PBM auditor treats the mismatch as a flagged claim.

Second, secondary wholesaler purchases. When you buy from a secondary wholesaler to maintain inventory during a shortage, the NDC on that invoice may differ from what you submitted on the original claim. The medication is identical. The documentation trail is just distributed across two suppliers instead of one.

Third, system-generated mismatches. Pharmacy management systems sometimes default to a specific NDC during claim transmission while your invoice records the actual dispensed NDC. This is a software configuration issue, not a dispensing issue. But it creates the exact discrepancy pattern PBMs look for in audits.

What each major PBM requires to overturn the finding

Every PBM provider manual specifies what documentation will satisfy an NDC discrepancy appeal. The standards vary significantly, and knowing the specific requirement for the PBM that sent you the notice can be the difference between a successful appeal and a clawback.

Optum Rx

Optum Rx generally requires a complete purchase history for the 30 days surrounding the audit period, including wholesaler invoices that explicitly show the substituted NDC and a written statement from the wholesaler confirming the substitution. Their provider manual treats purchase-order-to-invoice transformation as a valid explanation, but only when the chain is fully documented.

CVS Caremark

Caremark's standard is closer to strict matching. They typically require that the NDC on your claim match the NDC on your invoice, and appeals based on wholesaler substitution require a formal statement from the wholesaler documenting the substitution. If you cannot obtain that statement within the PBM's appeal window, the finding stands.

Express Scripts

Express Scripts accepts wholesaler substitution documentation but is specific about format. The invoice must show the substituted NDC, the purchase date, the quantity, and the wholesaler's DEA registration number. Generic statements from the wholesaler without transaction-specific detail are generally rejected.

Humana Pharmacy Solutions

Humana requires pharmacies to maintain contemporaneous records of substitutions. If you can show an internal log or electronic record that documents the substitution at the time of dispensing — not reconstructed after the audit — appeals succeed more often than with other PBMs.

Why "close enough" documentation fails

The hardest part of defending an NDC discrepancy finding is that most independent pharmacies have the right information somewhere. The problem is that it lives in three different systems that do not talk to each other: your pharmacy management system tracks the claim, your wholesaler portal tracks the invoice, and your inventory system tracks what you actually dispensed. Reconciling all three under audit pressure is where most pharmacies lose.

PBM auditors are not persuaded by approximation. If the invoice is missing a date stamp, if the substitution documentation is informal, or if the NDC sequence cannot be reconstructed cleanly from your records, the finding will generally be upheld — regardless of whether the underlying dispensing was correct.

What to do if you receive an NDC discrepancy notice

Read the notice carefully and identify which specific claims are flagged. Check the date range. Pull the wholesale invoices for those exact dates. Compare each flagged NDC against your invoice. Where a substitution occurred, request written confirmation from the wholesaler immediately — these requests can take 10 to 14 business days, and most PBM appeal windows are 30 days or less.

If the documentation trail has gaps, consider whether the gap is salvageable (invoice retrievable, wholesaler statement obtainable) or structural (invoice missing, wholesaler no longer active). For structural gaps, the appeal is unlikely to succeed on its own — at that point the question becomes whether the finding justifies the cost of legal counsel.

Most NDC discrepancy findings involve individual recoupments of a few hundred to a few thousand dollars. For a single finding, many pharmacies decide the documentation lift is not worth the recoverable amount. But PBMs often combine small findings across multiple audits to justify network termination later — which makes even small findings worth defending with proper documentation, not necessarily with a full appeal.